Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis Pharmaceuticals to provide corporate update and 30-year retrospective at its 2019 Annual Meeting of Stockholders

CARLSBAD, Calif. , June 6, 2019 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Stanley T. Crook , M.D., Ph.D., chairman of the board and chief executive officer, will present a general corporate update and 30-year retrospective in conjunction with its 2019 Annual